RNASEH2B and Glucose intolerance: ENALA treatment for 24 h upregulated RNASEH2B, which is associated with headache and glucose intolerance, and downregulated FBXW7 (F-box and WD repeat domain containing 7), which is associated with constipation, through miRNA regulation.